001     304285
005     20250907022520.0
024 7 _ |a 10.1038/s42255-025-01350-6
|2 doi
024 7 _ |a pmid:40890536
|2 pmid
024 7 _ |a altmetric:180883361
|2 altmetric
037 _ _ |a DKFZ-2025-01825
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Coleman, Olivia I
|0 0000-0002-4075-7820
|b 0
245 _ _ |a ATF6 activation alters colonic lipid metabolism causing tumour-associated microbial adaptation.
260 _ _ |a [London]
|c 2025
|b Springer Nature
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1756819028_26696
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a epub
520 _ _ |a Endoplasmic reticulum unfolded protein responses contribute to cancer development, with activating transcription factor 6 (ATF6) involved in microbiota-dependent tumorigenesis. Here we show the clinical relevance of ATF6 in individuals with early-onset and late colorectal cancer, and link ATF6 signalling to changes in lipid metabolism and intestinal microbiota. Transcriptional analysis in intestinal epithelial cells of ATF6 transgenic mice (nATF6IEC) identifies bacteria-specific changes in cellular metabolism enriched for fatty acid biosynthesis. Untargeted metabolomics and isotype labelling confirm ATF6-related enrichment of long-chain fatty acids in colonic tissue of humans, mice and organoids. FASN inhibition and microbiota transfer in germ-free nATF6IEC mice confirm the causal involvement of ATF6-induced lipid alterations in tumorigenesis. The selective expansion of tumour-relevant microbial taxa, including Desulfovibrio fairfieldensis, is mechanistically linked to long-chain fatty acid exposure using bioorthogonal non-canonical amino acid tagging, and growth analysis of Desulfovibrio isolates. We postulate chronic ATF6 signalling to select for tumour-promoting microbiota by altering lipid metabolism.
536 _ _ |a 314 - Immunologie und Krebs (POF4-314)
|0 G:(DE-HGF)POF4-314
|c POF4-314
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
700 1 _ |a Sorbie, Adam
|0 0000-0002-3330-4612
|b 1
700 1 _ |a Riva, Alessandra
|0 0000-0002-5724-7616
|b 2
700 1 _ |a von Stern, Miriam
|b 3
700 1 _ |a Kuhls, Stephanie
|b 4
700 1 _ |a Selegato, Denise M
|b 5
700 1 _ |a Siegert, Luisa
|b 6
700 1 _ |a Keidel, Isabel
|0 0009-0000-9806-1087
|b 7
700 1 _ |a Köhler, Nikolai
|0 0000-0002-5103-883X
|b 8
700 1 _ |a Wirbel, Jakob
|0 0000-0002-4073-3562
|b 9
700 1 _ |a Kacprowski, Tim
|0 0000-0002-5393-2413
|b 10
700 1 _ |a Dunkel, Andreas
|b 11
700 1 _ |a Pauling, Josch K
|b 12
700 1 _ |a Plagge, Johannes
|b 13
700 1 _ |a Mediel-Cuadra, Diego
|b 14
700 1 _ |a Wagner, Sophia J
|b 15
700 1 _ |a Chadly, Ines
|b 16
700 1 _ |a Bierwith, Sandra
|b 17
700 1 _ |a Peng, Tingying
|b 18
700 1 _ |a Metzler, Thomas
|0 0000-0002-1620-5559
|b 19
700 1 _ |a Li, Xin-Feng
|0 P:(DE-He78)0d56bfbd4cd4cf94f34df200f9d9f7c1
|b 20
700 1 _ |a Heikenwälder, Mathias
|0 P:(DE-He78)66ed2d4ec9bc11d29b87ac006adf85e5
|b 21
|u dkfz
700 1 _ |a Schafmayer, Clemens
|b 22
700 1 _ |a Hinz, Sebastian
|b 23
700 1 _ |a Röder, Christian
|b 24
700 1 _ |a Röcken, Christoph
|b 25
700 1 _ |a Zimmermann, Michael
|0 0000-0002-5797-3589
|b 26
700 1 _ |a Rosenstiel, Philip
|0 0000-0002-9692-8828
|b 27
700 1 _ |a Steiger, Katja
|b 28
700 1 _ |a Jesinghaus, Moritz
|b 29
700 1 _ |a Liebisch, Gerhard
|0 0000-0003-4886-0811
|b 30
700 1 _ |a Ecker, Josef
|0 0000-0003-4799-0788
|b 31
700 1 _ |a Schmidt, Christina
|0 0000-0002-3867-0881
|b 32
700 1 _ |a Zeller, Georg
|b 33
700 1 _ |a Janssen, Klaus-Peter
|0 0000-0002-4707-7887
|b 34
700 1 _ |a Haller, Dirk
|0 0000-0002-6977-4085
|b 35
773 _ _ |a 10.1038/s42255-025-01350-6
|0 PERI:(DE-600)2933873-6
|p nn
|t Nature metabolism
|v nn
|y 2025
|x 2522-5812
909 C O |o oai:inrepo02.dkfz.de:304285
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 20
|6 P:(DE-He78)0d56bfbd4cd4cf94f34df200f9d9f7c1
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 21
|6 P:(DE-He78)66ed2d4ec9bc11d29b87ac006adf85e5
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-314
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Immunologie und Krebs
|x 0
914 1 _ |y 2025
915 _ _ |a DEAL Nature
|0 StatID:(DE-HGF)3003
|2 StatID
|d 2024-12-16
|w ger
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b NAT METAB : 2022
|d 2024-12-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2024-12-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2024-12-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2024-12-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2024-12-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2024-12-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2024-12-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2024-12-16
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2024-12-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2024-12-16
915 _ _ |a IF >= 20
|0 StatID:(DE-HGF)9920
|2 StatID
|b NAT METAB : 2022
|d 2024-12-16
920 1 _ |0 I:(DE-He78)D440-20160331
|k D440
|l Chronische Entzündung und Krebs
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)D440-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21